OOIR: Observatory of International Research

Papers

(The H4-Index of Military Medical Research is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Substantia nigra-related gene polymorphisms associated with acute antipsychotic-induced movement disorders	337
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression	319
Mesenchymal stem cell-derived extracellular vesicles in skin wound healing: roles, opportunities and challenges	202
Are metformin-based combination approaches beneficial for non-small cell lung cancer: evidence from experimental and clinical studies	155
Oral administration of asparagine and 3-indolepropionic acid prolongs survival time of rats with traumatic colon injury	144
Correction to: Bioengineered materials with selective antimicrobial toxicity in biomedicine	121
Bone-organ axes: bidirectional crosstalk	114
National and subnational burden and causes of anemia in China from 1990 to 2023: findings from the Global Burden of Disease Study 2023	105
Nanozyme-driven multifunctional dressings: moving beyond enzyme-like catalysis in chronic wound treatment	97
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies	85
Explosive eye injuries: characteristics, traumatic mechanisms, and prognostic factors for poor visual outcomes	83
The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives	79
A comprehensive look at the psychoneuroimmunoendocrinology of spinal cord injury and its progression: mechanisms and clinical opportunities	76
The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer	70
Adipose tissue macrophages: implications for obesity-associated cancer	69
Introduction of monkeypox virus in Benin, 2022	64
Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research	59
Targeting the epigenome to reinvigorate T cells for cancer immunotherapy	53
FDA-approved cannabidiol [Epidiolex®] alleviates Gulf War Illness-linked cognitive and mood dysfunction, hyperalgesia, neuroinflammatory signaling, and declined neurogenesis	52
The Frank-Starling mechanism is not enough: blood volume expansion prominently decreases pulmonary O2 uptake	52
Chinese expert consensus on prevention, diagnosis, and management of venous thromboembolism in adult burn patients (2024)	50
Engineered immune-driven theranostics for clinical cardiology	45
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathy	44
Neuroinflammation in mild respiratory COVID-19: insights into cognitive impairment in milder cases	44
Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases	43

Dual-locked targeted alpha-emitter enhanced tumor immunotherapy via Diels–Alder reaction-based self-immolative molecular cage strategy	42
Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity	42
Research advances in smart responsive-hydrogel dressings with potential clinical diabetic wound healing properties	40
γ neuromodulations: unraveling biomarkers for neurological and psychiatric disorders	40
Artificial intelligence and machine learning for hemorrhagic trauma care	40
Guidance of development, validation, and evaluation of algorithms for populating health status in observational studies of routinely collected data (DEVELOP-RCD)	39
Ionizable drug delivery systems for efficient and selective gene therapy	38
Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases	37
Immune cells: potential carriers or agents for drug delivery to the central nervous system	37
Risk factor control in relation to mortality and life expectancy among people with type 2 diabetes: results from 3 nationwide cohort studies	37
Recent developments in application of single-cell RNA sequencing in the tumour immune microenvironment and cancer therapy	36